gastric cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Aged between 18 and 75 years, male and female; (2) patients with gastric cancerdiagnosed by cytological or histological examination, requires surgical treatment; (3) ECOG score0/1 preoperation; (4) ASA soore I-III preoperation; (5) Informed consent was signed as voluntarily before study; (6) Patients with no other malignant tumors at the same time; without having surgery history of gastric resection.
Exclusion criteria
Exclusion criteria: 1. Patients with other malignant tumors at the same time; 2. patients having surgery history of gastric resection; 3. patients having a history of mediastinal surgery or vast peritoneal adhesion; 4. patients with heart thromboembolism at the same time; 5. People with psychological, mental or nervous system diseases; 6. Cachexia, severe malnutrition patients; 7. Patients with history of recent recurrence of gastric ulcer, stomach bleeding and other severe basic diseases; 8. Patients with blood coagulation dysfunction, HIV antibody positive, or surgical contraindications such as clinically poorly controlled serious infection; 9. The subjects with other associated disease (such as liver and renal dysplasia, etc.) or drug combination, which could influence the study results recognized by the researchers; 10. Patients participating in another clinical study; 11. Patients with surgical instruments material allergy, or allergic constitution; 12. The subjects are not judged by investigator to participate in this Clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of intraoperative lymph node dissection;Conversion rate of single incision laparoscopic surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| the first flatus post operation;the first defecation time post operation;the first time to eat forming food post operation;independent ambulation time after operation;post operation hospitalizaition time;post operation pain score;umbilical incision length;operation time;inflamatory biomarker; | — |
Countries
China
Contacts
Second affiliated hospital, Army Medical University